# A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

> **NCT00151515** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Consumer and Personal Products Worldwide** · enrollment: 352 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** minoxidil

## Key facts

- **NCT ID:** NCT00151515
- **Lead sponsor:** Johnson & Johnson Consumer and Personal Products Worldwide
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2016-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151515, "A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00151515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*